How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Naoya, Kuno, Ikumi, Yoshida, Hiroshi, Shiraishi, Kouya, Kato, Tomoyasu, Igaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oncology/Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944302/
https://www.ncbi.nlm.nih.gov/pubmed/35039847
http://dx.doi.org/10.1093/jrr/rrab130
_version_ 1784673683185336320
author Murakami, Naoya
Kuno, Ikumi
Yoshida, Hiroshi
Shiraishi, Kouya
Kato, Tomoyasu
Igaki, Hiroshi
author_facet Murakami, Naoya
Kuno, Ikumi
Yoshida, Hiroshi
Shiraishi, Kouya
Kato, Tomoyasu
Igaki, Hiroshi
author_sort Murakami, Naoya
collection PubMed
description We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be obtained prior to treatment, and they might classify patients earlier.
format Online
Article
Text
id pubmed-8944302
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89443022022-03-28 How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment? Murakami, Naoya Kuno, Ikumi Yoshida, Hiroshi Shiraishi, Kouya Kato, Tomoyasu Igaki, Hiroshi J Radiat Res Oncology/Medicine We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be obtained prior to treatment, and they might classify patients earlier. Oxford University Press 2022-01-18 /pmc/articles/PMC8944302/ /pubmed/35039847 http://dx.doi.org/10.1093/jrr/rrab130 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oncology/Medicine
Murakami, Naoya
Kuno, Ikumi
Yoshida, Hiroshi
Shiraishi, Kouya
Kato, Tomoyasu
Igaki, Hiroshi
How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
title How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
title_full How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
title_fullStr How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
title_full_unstemmed How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
title_short How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
title_sort how should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
topic Oncology/Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944302/
https://www.ncbi.nlm.nih.gov/pubmed/35039847
http://dx.doi.org/10.1093/jrr/rrab130
work_keys_str_mv AT murakaminaoya howshouldweappropriatelyclassifylowriskuterinecervicalcancerpatientssuitablefordeintensifiedtreatment
AT kunoikumi howshouldweappropriatelyclassifylowriskuterinecervicalcancerpatientssuitablefordeintensifiedtreatment
AT yoshidahiroshi howshouldweappropriatelyclassifylowriskuterinecervicalcancerpatientssuitablefordeintensifiedtreatment
AT shiraishikouya howshouldweappropriatelyclassifylowriskuterinecervicalcancerpatientssuitablefordeintensifiedtreatment
AT katotomoyasu howshouldweappropriatelyclassifylowriskuterinecervicalcancerpatientssuitablefordeintensifiedtreatment
AT igakihiroshi howshouldweappropriatelyclassifylowriskuterinecervicalcancerpatientssuitablefordeintensifiedtreatment

Ejemplares similares